- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 11.55M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $754.48M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $532.47M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $522.68M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $453.33M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.76B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.76B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.31B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.23B |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 12.62M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $557K |
| Capex | Q1 2025 · Mar 31, 2024 | $946K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $181.99M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $3.81 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $4.76 |
| Net Income | Q1 2025 · Mar 31, 2024 | $47.61M |
| Revenue | Q1 2025 · Mar 31, 2024 | $206.61M |